Literature DB >> 15934171

NKG2D in innate and adaptive immunity.

Lewis L Lanier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15934171     DOI： 10.1007/0-387-24180-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  9 in total

1.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT.

Authors:  Mobin A Karimi; Jerrod L Bryson; Lee P Richman; Andrew D Fesnak; Theresa M Leichner; Atsushi Satake; Robert H Vonderheide; David H Raulet; Ran Reshef; Taku Kambayashi
Journal:  Blood       Date:  2015-03-18       Impact factor: 22.113

3.  Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

Authors:  Galit Alter; Stephanie Jost; Suzannah Rihn; Laura L Reyor; Brian E Nolan; Musie Ghebremichael; Ronald Bosch; Marcus Altfeld; Georg M Lauer
Journal:  J Hepatol       Date:  2010-12-17       Impact factor: 25.083

4.  Copy number variation in the mouse genome: implications for the mouse as a model organism for human disease.

Authors:  G Cutler; P D Kassner
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

5.  NKG2D splice variants: a reexamination of adaptor molecule associations.

Authors:  Brian Rabinovich; Jennifer Li; Martin Wolfson; William Lawrence; Courtney Beers; Jan Chalupny; Rose Hurren; Brad Greenfield; Richard Miller; David Cosman
Journal:  Immunogenetics       Date:  2006-02-10       Impact factor: 2.846

6.  Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.

Authors:  Geoffrey O Gillard; Maytal Bivas-Benita; Avi-Hai Hovav; Lauren E Grandpre; Michael W Panas; Michael S Seaman; Barton F Haynes; Norman L Letvin
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

7.  Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Matteo Santoni; Alessandra Soriani; Massimo Nabissi; Claudio Cardinali; Angela Santoni; Giorgio Santoni
Journal:  Oncotarget       Date:  2015-11-03

8.  Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases.

Authors:  Jean Baptiste Haumonte; Sophie Caillat-Zucman; Florence Bretelle; Marion Lambert; Luc Lyonnet; Annie Levy-Mozziconacci; Catherine Farnarier; Agostini Aubert; Leon Boubli; Laurence Camoin-Jau; Françoise Dignat George; Pascale Paul
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 9.  NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.

Authors:  Dominik Schmiedel; Ofer Mandelboim
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.